BACKGROUND: Diet is a key component of a healthy lifestyle in the prevention of type 2 diabetes mellitus (T2DM). The role of long-chain omega-3 (n-3) fatty acids (LCFAs) in the development of T2DM remains unresolved. OBJECTIVE: We examined the association between dietary LCFAs and incidence of T2DM in 3 prospective cohorts of women and men. DESIGN: We followed 195,204 US adults (152,700 women and 42,504 men) without preexisting chronic disease at baseline for 14 to 18 y. Fish and LCFA intakes were assessed at baseline and updated at 4-y intervals by using a validated food-frequency questionnaire. RESULTS: During nearly 3 million person-years of follow-up, 9380 new cases of T2DM were documented. After adjustment for other dietary and lifestyle risk factors, LCFA intake was positively related to incidence of T2DM. The pooled multivariate relative risks in 3 cohorts across increasing quintiles of LCFAs were as follows: 1 (reference), 1.00 (95% CI: 0.91, 1.09), 1.05 (95% CI: 0.97, 1.13), 1.17 (95% CI: 1.07, 1.28), and 1.24 (95% CI: 1.09, 1.40) (P for trend < 0.001). Compared with those who consumed fish less than once per month, the relative risk of T2DM was 1.22 (95% CI: 1.08, 1.39) for women who consumed > or =5 servings fish/wk (P for trend <0.001). CONCLUSIONS: We found no evidence that higher consumption of LCFAs and fish reduces the risk of T2DM. Instead, higher intakes may modestly increase the incidence of this disease. Given the beneficial effects of LCFA intake on many cardiovascular disease risk factors, the clinical relevance of this relation and its possible mechanisms require further investigation.
BACKGROUND: Diet is a key component of a healthy lifestyle in the prevention of type 2 diabetes mellitus (T2DM). The role of long-chain omega-3 (n-3) fatty acids (LCFAs) in the development of T2DM remains unresolved. OBJECTIVE: We examined the association between dietary LCFAs and incidence of T2DM in 3 prospective cohorts of women and men. DESIGN: We followed 195,204 US adults (152,700 women and 42,504 men) without preexisting chronic disease at baseline for 14 to 18 y. Fish and LCFA intakes were assessed at baseline and updated at 4-y intervals by using a validated food-frequency questionnaire. RESULTS: During nearly 3 million person-years of follow-up, 9380 new cases of T2DM were documented. After adjustment for other dietary and lifestyle risk factors, LCFA intake was positively related to incidence of T2DM. The pooled multivariate relative risks in 3 cohorts across increasing quintiles of LCFAs were as follows: 1 (reference), 1.00 (95% CI: 0.91, 1.09), 1.05 (95% CI: 0.97, 1.13), 1.17 (95% CI: 1.07, 1.28), and 1.24 (95% CI: 1.09, 1.40) (P for trend < 0.001). Compared with those who consumed fish less than once per month, the relative risk of T2DM was 1.22 (95% CI: 1.08, 1.39) for women who consumed > or =5 servings fish/wk (P for trend <0.001). CONCLUSIONS: We found no evidence that higher consumption of LCFAs and fish reduces the risk of T2DM. Instead, higher intakes may modestly increase the incidence of this disease. Given the beneficial effects of LCFA intake on many cardiovascular disease risk factors, the clinical relevance of this relation and its possible mechanisms require further investigation.
Authors: Duk-Hee Lee; In-Kyu Lee; Kyungeun Song; Michael Steffes; William Toscano; Beth A Baker; David R Jacobs Journal: Diabetes Care Date: 2006-07 Impact factor: 19.112
Authors: Ingrid L Mostad; Kristian S Bjerve; Marit R Bjorgaas; Stian Lydersen; Valdemar Grill Journal: Am J Clin Nutr Date: 2006-09 Impact factor: 7.045
Authors: Allison M Hodge; Dallas R English; Kerin O'Dea; Andrew J Sinclair; Maria Makrides; Robert A Gibson; Graham G Giles Journal: Am J Clin Nutr Date: 2007-07 Impact factor: 7.045
Authors: Sven O E Ebbesson; M Elizabeth Tejero; Elizabeth D Nobmann; Juan Carlos Lopez-Alvarenga; Lars Ebbesson; Terri Romenesko; Elizabeth A Carter; Helaine E Resnick; Richard B Devereux; Jean W MacCluer; Bennett Dyke; Sandra L Laston; Charlotte R Wenger; Richard R Fabsitz; Anthony G Comuzzie; Barbara V Howard Journal: J Cardiometab Syndr Date: 2007
Authors: Maria A Lankinen; Alena Stančáková; Matti Uusitupa; Jyrki Ågren; Jussi Pihlajamäki; Johanna Kuusisto; Ursula Schwab; Markku Laakso Journal: Diabetologia Date: 2015-08-16 Impact factor: 10.122
Authors: Jason H Y Wu; Renata Micha; Fumiaki Imamura; An Pan; Mary L Biggs; Owais Ajaz; Luc Djousse; Frank B Hu; Dariush Mozaffarian Journal: Br J Nutr Date: 2012-06 Impact factor: 3.718
Authors: Sylvia H Ley; An Pan; Yanping Li; JoAnn E Manson; Walter C Willett; Qi Sun; Frank B Hu Journal: Diabetes Care Date: 2016-09-15 Impact factor: 19.112
Authors: Philippe Grandjean; Jan Erik Henriksen; Anna L Choi; Maria Skaalum Petersen; Christine Dalgård; Flemming Nielsen; Pal Weihe Journal: Epidemiology Date: 2011-05 Impact factor: 4.822
Authors: Ju-Sheng Zheng; Donna K Arnett; Laurence D Parnell; Yu-Chi Lee; Yiyi Ma; Caren E Smith; Kris Richardson; Duo Li; Ingrid B Borecki; Jose M Ordovas; Katherine L Tucker; Chao-Qiang Lai Journal: J Nutr Date: 2013-01-09 Impact factor: 4.798